J. Ong et al., DIFFERENTIAL-EFFECTS OF PHOSPHONIC ANALOGS OF GABA ON GABA(B) AUTORECEPTORS IN RAT NEOCORTICAL SLICES, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 408-412
The effects of five phosphonic derivatives of GABA on the release of [
H-3]-GABA from rat neocortical slices, preloaded with [3H]-GABA, were
investigated. Phaclofen and 4-aminobutylphosphonic acid (4-ABPA) incre
ased the overflow of [H-3] evoked by electrical stimulation (2 Hz) in
a concentration-dependent manner, with similar potencies (phaclofen EC
50 = 0.3 mmol/l, 4-ABPA EC50 = 0.4 mmol/l). At 3 mmol/l, phaclofen inc
reased the release of [H-3]-GABA by 82.6+/-8.6%, and 4-ABPA increased
the release by 81.3+/-9.0%. 2-Amino-ethylphosphonic acid (2-AEPA) incr
eased the overflow of [H-3] by 46.8+/-10.9% at the highest concentrati
on tested (3 mmol/l). In contrast, the lower phosphonic homologue 3-am
inopropylphosphonic acid (3-APPA), and 2-amino-2-(p-chlorophenyl)-ethy
lphosphonic acid (2-CPEPA), a baclofen analogue, did not modify the st
imulated overflow. These results suggest that phaclofen, 4-ABPA and 2-
AEPA are antagonists at GABA(B) autoreceptors, the latter being the we
akest antagonist, whilst neither 3-APPA nor 2-CPEPA are active at thes
e receptors. Since phaclofen, 4-ABPA and 2-CPEPA are antagonists and 3
-APPA a partial agonist/antagonist on GABA(B) heteroreceptors, the lac
k of effect of 3-APPA and 2-CPEPA on [H-3]-GABA release in this study
suggests that GABA(B) autoreceptors may be pharmacologically distinct
from the heteroreceptors.